INA – SOURCES
The University of Oxford and AstraZeneca have restarted a UK trial of an experimental COVID-19 vaccine after it was halted over concerns about a participant who fell ill.
The UK Medicines Health Regulatory Authority recommended that the study resume after an independent review of the safety data triggered a pause on Sept. 6, Oxford said in a statement. It declined to disclose details about the volunteer’s illness.
While temporary halts are common in vaccine trials, the interruption to the closely watched Astra-Oxford study had raised concerns about the viability of one of the fastest-moving experimental shots seeking protection from the pandemic. The race to develop a COVID-19 vaccine has compressed what is normally a decade-long process into a matter of months, with data from final-stage trials expected as soon as next month.
Prime Minister received Chairman JP Morgan Bank
ICAA announces the reopening of Iraqi airspace
Experts and lawmakers emphasize the strategic significance of Al-Sudani's visit to Washington
The Prime Minister arrives in Washington, DC
PM Al-Sudani meets US President Biden at the White House